RE:Canadian Press April 10, 2014Hi GV.
Well at the end of the day the stock value is going to be about (perceived) substance...does a drug or molecule have a high probability of success.
Yet the market timing is what I was concerned about for Zenith 6 months ago when the pharma IPO market was hot.
Anyway, if the Zenith platforms are effective machinery/platforms, I don't think the market will drag down the valuation significantly, IMO. Just my guess. I just wonder what they at Zenith are doing.
Cheers
Toinv